Background
- Leucine-rich repeat-containing protein 15 (LRRC15) has emerged as a potential biomarker and therapeutic target for various cancers due to its high expression in cancer-associated fibroblasts (CAFs) and role in tumor progression.
- High LRRC15 expression is associated with poor prognosis in Triple Negative Breast Cancer (TNBC).
- This study aims to define the multiomic profile of LRRC15 in TNBC.